<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-09-20T00:39:43Z</responseDate><request verb="GetRecord" identifier="oai:wakespace.lib.wfu.edu:10339/14772" metadataPrefix="dim">https://wakespace.lib.wfu.edu/server/oai/request</request><GetRecord><record><header><identifier>oai:null:10339/14772</identifier><datestamp>2026-09-18T14:10:04Z</datestamp><setSpec>com_10339_14934</setSpec><setSpec>col_10339_38132</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="author" lang="en_US">Tuncer, Feyza</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned" lang="en_US">2009-04-01T15:29:03Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2010-06-18T18:58:31Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available" lang="en_US">2009-04-01T15:29:03Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2010-06-18T18:58:31Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued" lang="en_US">2009-04-01T15:29:03Z</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://wakespace.lib.wfu.edu/handle/10339/14772</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract" lang="en_US">Type 2 diabetes mellitus is a complex disorder caused by elevated blood glucose
levels that arise from peripheral insulin resistance and/or impaired insulin secretion from
the pancreatic beta-cells. It is a global epidemic affecting millions of people around the
world, bringing serious economic burden to health care systems. Thus, the underlying
components of this disorder are under extensive investigation. The interest of my thesis
project has been on the insulin secretion phenotype of type 2 diabetes. Therefore, a highthroughput
surrogate cell-based assay for pancreatic beta-cell insulin secretion has been
developed through which the screen of novel genes and the genes having genetic
evidences of susceptibility to type 2 diabetes were screened, in order to assign them
pertinent roles in beta-cell secretory function. In this respect, we have screened the
Insulin Resistance Atherosclerosis Family Study (IRASFS) positional candidate genes
and the Wnt signaling pathway components, where the genes with significant impacts on
glucose-stimulated secretion were subject to further delineation. The IRASFS gene list
was established through linkage analysis of quantitative trait loci for measures of glucose
homeostasis by our collaborator. Our aim was to add a functional layer to the genetic
evidence through the screens performed on IRASFS genes. On the other hand, previous
reports have shown the involvement of several Wnt signaling pathway components in
beta-cell secretory function. In this respect, the strongest evidence comes from
x
independent genomic studies that have highly associated the development of type 2
diabetes and impaired insulin secretion to the polymorphisms within the TCF7L2 gene. In
addition, an active Wnt signaling pathway was suggested in the mouse and human
pancreas by the confirmed expressions of several Wnt and Frizzled isoforms, along with
the evidence highlighting the requirement of the co-receptor LRP5 for glucose-stimulated
insulin secretion (GSIS) in the mouse islets. We have performed a general screen on the
Wnt signaling pathway components in order to complete the picture between the genes
TCF7L2 and LRP5 and to delineate this pathway with respect to beta-cell secretory
function. Our findings have validated the importance of this pathway, where a β-catenin
dependent path of glucose-induced insulin secretion is suggested.</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso" lang="en_US">en_US</dim:field>
   <dim:field mdschema="dc" element="publisher" lang="en_US">Wake Forest University</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Genes</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Beta-Cell</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Pancreas</dim:field>
   <dim:field mdschema="dc" element="title" lang="en_US">Identifying Genes in Pancreatic Beta-Cell Function using a Novel High-Thoughput Cell-Based Screening Assay</dim:field>
   <dim:field mdschema="dc" element="type" lang="en_US">Dissertation</dim:field>
   <dim:field mdschema="dc" element="type" lang="en_US">Thesis</dim:field>
   <dim:field mdschema="dc" element="rights" qualifier="accessRights" lang="en_US">Release the entire work immediately for access worldwide.</dim:field>
   <dim:field mdschema="thesis" element="contributor" qualifier="committeeChair" lang="en_US">Dr. Peter A. Antinozzi</dim:field>
   <dim:field mdschema="thesis" element="contributor" qualifier="committeeMember" lang="en_US">Dr. Donald W. Bowden</dim:field>
   <dim:field mdschema="thesis" element="contributor" qualifier="committeeMember" lang="en_US">Dr. Yuh-Hwa Wang</dim:field>
   <dim:field mdschema="thesis" element="contributor" qualifier="committeeMember" lang="en_US">Dr. Bingzhong Xue</dim:field>
   <dim:field mdschema="thesis" element="degree" qualifier="discipline" lang="en_US">Molecular Genetics</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
</dim:dim>
</metadata></record></GetRecord></OAI-PMH>